Literature DB >> 24406863

Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma.

Patrick J Cimino1, Diane H Robirds1, Sheryl R Tripp2, John D Pfeifer1, Haley J Abel3, Eric J Duncavage1.   

Abstract

Merkel cell carcinoma is a highly aggressive cutaneous neuroendocrine tumor that has been associated with Merkel cell polyomavirus in up to 80% of cases. Merkel cell polyomavirus is believed to influence pathogenesis, at least in part, through expression of the large T antigen, which includes a retinoblastoma protein-binding domain. However, there appears to be significant clinical and morphological overlap between polyomavirus-positive and polyomavirus-negative Merkel cell carcinoma cases. Although much of the recent focus of Merkel cell carcinoma pathogenesis has been on polyomavirus, the pathogenesis of polyomavirus-negative cases is still poorly understood. We hypothesized that there are underlying human somatic mutations that unify Merkel cell carcinoma pathogenesis across polyomavirus status, and to investigate we performed whole exome sequencing on five polyomavirus-positive cases and three polyomavirus-negative cases. We found that there were no significant differences in the overall number of single-nucleotide variations, copy number variations, insertion/deletions, and chromosomal rearrangements when comparing polyomavirus-positive to polyomavirus-negative cases. However, we did find that the retinoblastoma pathway genes harbored a high number of mutations in Merkel cell carcinoma. Furthermore, the retinoblastoma gene (RB1) was found to have nonsense truncating protein mutations in all three polyomavirus-negative cases; no such mutations were found in the polyomavirus-positive cases. In all eight cases, the retinoblastoma pathway dysregulation was confirmed by immunohistochemistry. Although polyomavirus-positive Merkel cell carcinoma is believed to undergo retinoblastoma dysregulation through viral large T antigen expression, our findings demonstrate that somatic mutations in polyomavirus-negative Merkel cell carcinoma lead to retinoblastoma dysregulation through an alternative pathway. This novel finding suggests that the retinoblastoma pathway dysregulation leads to an overlapping Merkel cell carcinoma phenotype and that oncogenesis occurs through either a polyomavirus-dependent (viral large T antigen expression) or polyomavirus-independent (host somatic mutation) mechanism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24406863     DOI: 10.1038/modpathol.2013.235

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  31 in total

1.  Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus.

Authors:  Andrew G Miner; Rajiv M Patel; Deborah A Wilson; Gary W Procop; Eugen C Minca; Douglas R Fullen; Paul W Harms; Steven D Billings
Journal:  Mod Pathol       Date:  2014-11-14       Impact factor: 7.842

2.  p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas.

Authors:  Llucia Alos; Sofia Hakim; Ana-Belen Larque; Jorge de la Oliva; Leonardo Rodriguez-Carunchio; Miguel Caballero; Alfons Nadal; Carles Marti; Nuria Guimera; Maria-Teresa Fernandez-Figueras; Wim Quint; Jaume Ordi
Journal:  Virchows Arch       Date:  2016-07-08       Impact factor: 4.064

3.  Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.

Authors:  Kelly L Harms; Lorena Lazo de la Vega; Daniel H Hovelson; Samantha Rahrig; Andi K Cani; Chia-Jen Liu; Douglas R Fullen; Min Wang; Aleodor A Andea; Christopher K Bichakjian; Timothy M Johnson; Scott A Tomlins; Paul W Harms
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

4.  Higher Expression of Activation-induced Cytidine Deaminase Is Significantly Associated with Merkel Cell Polyomavirus-negative Merkel Cell Carcinomas.

Authors:  Michiko Matsushita; Takeshi Iwasaki; Daisuke Nonaka; Satoshi Kuwamoto; Keiko Nagata; Masako Kato; Yukisato Kitamura; Kazuhiko Hayashi
Journal:  Yonago Acta Med       Date:  2017-09-15       Impact factor: 1.641

Review 5.  Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Authors:  Teresa Amaral; Ulrike Leiter; Claus Garbe
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

6.  Merkel cell carcinoma masquerading as cellulitis: a case report and review of the literature.

Authors:  F Safa; M Pant; C Weerasinghe; R Felix; T Terjanian
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

7.  Hedgehog Signaling Inhibitors Fail to Reduce Merkel Cell Carcinoma Viability.

Authors:  Thomas M Carroll; Jonathan S Williams; Kenneth Daily; Tova Rogers; Tara Gelb; Amy Coxon; Steven Q Wang; Aimee M Crago; Klaus J Busam; Isaac Brownell
Journal:  J Invest Dermatol       Date:  2017-01-25       Impact factor: 8.551

8.  A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel.

Authors:  Patrick J Cimino; Andy Bredemeyer; Haley J Abel; Eric J Duncavage
Journal:  Exp Mol Pathol       Date:  2015-04-22       Impact factor: 3.362

Review 9.  Proceedings of the NASHNP Companion Meeting, March 18th, 2018, Vancouver, BC, Canada: Salivary Neuroendocrine Carcinoma-An Overview of a Rare Disease with an Emphasis on Determining Tumor Origin.

Authors:  Rebecca D Chernock; Eric J Duncavage
Journal:  Head Neck Pathol       Date:  2018-03-20

10.  Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.

Authors:  Paul W Harms; Angela M B Collie; Daniel H Hovelson; Andi K Cani; Monique E Verhaegen; Rajiv M Patel; Douglas R Fullen; Kei Omata; Andrzej A Dlugosz; Scott A Tomlins; Steven D Billings
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.